The Scientist

» pharmaceuticals and microbiology

Most Recent

image: Shire to Buy Baxalta for $32 Billion

Shire to Buy Baxalta for $32 Billion

By | January 12, 2016

The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.

0 Comments

image: Counting Cells

Counting Cells

By | January 11, 2016

A person likely carries the same number of human and microbial cells, according to a new estimate.

1 Comment

image: Thermo Fisher to Acquire Affymetrix

Thermo Fisher to Acquire Affymetrix

By | January 11, 2016

The boards of both companies have agreed to a $1.3 billion deal, which is subject to Affymetrix shareholder approval.

0 Comments

image: All Together Now

All Together Now

By | January 1, 2016

Understanding the biological roots of cooperation might help resolve some of the biggest scientific challenges we face.

1 Comment

image: Bayer Enters CRISPR Field

Bayer Enters CRISPR Field

By | December 22, 2015

The pharmaceutical company will spend $335 million on a new venture with biotech startup CRISPR Therapeutics.

0 Comments

image: Researchers Accused of Spreading Disease

Researchers Accused of Spreading Disease

By | December 21, 2015

Italian scientists are under investigation for allegedly worsening the transmission of a pathogen that is decimating olive groves in Puglia.

0 Comments

image: First Dengue Vax Approved

First Dengue Vax Approved

By | December 11, 2015

Mexico’s health ministry has OKed the vaccine for people between nine and 45 years old.

0 Comments

image: Gut Bugs Affect Cockroach Poop-ularity

Gut Bugs Affect Cockroach Poop-ularity

By | December 9, 2015

Commensal bacteria living in the gastrointestinal tracts of cockroaches lace the insects’ feces with chemical cues that mediate social behavior, according to a study.

1 Comment

image: Metformin Users Have Different Gut Bugs

Metformin Users Have Different Gut Bugs

By | December 6, 2015

The popular type 2 diabetes drug may cause profound changes in patients’ microbiomes.

0 Comments

image: Daraprim Discounts Offered

Daraprim Discounts Offered

By | November 26, 2015

Turing Pharmaceuticals will soon offer discounts to hospitals for its toxoplasmosis-fighting drug, the company announced, but some say the proposed price reductions are not enough.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham